Brief: Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study For Breakthrough Hearing Device
01/11/2024 12:01
Nov 1 (Reuters) - Envoy Medical Inc COCH.O :
* ENVOY MEDICAL RECEIVES FDA APPROVAL TO INITIATE PIVOTAL
CLINICAL
STUDY FOR BREAKTHROUGH HEARING DEVICE
Source text: ID:nGNX285j6G
Further company coverage: COCH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Envoy Medical
See all newsBrief: Envoy Medical - Enters Dismissal Agreement With Atlas Merchant Capital Regarding Delaware Litigation, On Oct 6
Envoy Medical Inc expected to post a loss of 9 cents a share - Earnings Preview
Envoy expects U.S.-Turkey to 'soon' solve issue of sanctions over S-400 defences
Brief: Envoy Medical Receives FDA Approval To Advance Its Clinical Trial To Final Stage
Brief: Envoy Medical Enters Satisfaction Agreement With GAT Funding On Aug 25 - SEC Filing